-
Product Insights
Pear Tree Solar Farm, UK
Pear Tree Solar Farm is proposed to be developed in England, United Kingdom. Empower your strategies with our Pear Tree Solar Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Product Insights
Los Peares Grupo
Los Peares Grupo is a Hydro project located in Lugo, Spain. The project is owned by Naturgy Energy Group SA and was developed by Enel Union Fenosa Renovables, S.A. (Inactive). The project came online in 1953. Empower your strategies with our Los Peares Grupo report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Thematic Analysis
Edtech – Thematic Intelligence
Edtech Thematic Intelligence Report Overview Education technology (EdTech) gained prominence during the COVID-19 pandemic as travel restrictions forced schools and other educational institutions to teach online. The technologies that comprise edtech include artificial intelligence (AI), which aids in content creation, the customization of learning processes, evaluating performances, ensuring real-time communication, and automating grading. Additionally, VR and AR create appealing environments for students through virtual elements and situations. In an AR and VR classroom setup, both teachers and students perform tasks...
-
Thematic Analysis
State of the Biopharmaceutical Industry in 2024 – Thematic Intelligence
Accessing in-depth insights from the ‘State of the Biopharmaceutical Industry’ report will help you in: Examining the current attitudes of business leaders toward the emerging trends impacting the biopharmaceutical industry in the next 12 months. Benchmarking the impact of major themes on the biopharmaceutical industry in 2024, including emerging technologies, regulatory trends, macroeconomic trends, and industry trends. Identifying the most impactful anticipated regulatory approvals and drug launches in the industry in 2024, learning about top-selling drugs (2023 vs 2024), and obtaining...
-
Thematic Analysis
Digital Therapeutics – Thematic Intelligence
Explore actionable trends and insights with the following data sets in the ‘Digital Therapeutics’ report: Market analysis of approved and reimbursed digital therapeutic products by region. Case studies with in-depth insight into some of the most recent and most influential developments in the digital therapeutics theme. Product profiles of disruptive digital therapeutic products across key therapeutic areas. A focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting digital therapeutics, and a review of how these trends will...
-
Track & Monitor
Cybersecurity in Healthcare: Drug Delivery Device Security
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the healthcare industry’s Drug Delivery Device Security segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Company Profile
Ebro Foods SA – Company Profile
Ebro Foods SA (Ebro) is a manufacturer and distributor of pasta, rice and sauces. The company’s product portfolio includes dry, fresh, pre-cooked and frozen pastas, ready meals, fresh gnocchi, sauces and other related products. Ebro also provides short-grain rice and basmati rice. It markets products under Peacock, Phoenix, Saludades, Carolina Rice, the Sundari, Rocio, La Cigala, Santa Rita, Arotz, Garofalo, Minute Rice, Vegetalia, Santa Lucia, Bertagni, Russo, Panzani, Ferrero, Lustucru, Roland Monterrat, Regia, Taureau Aile, New Mill, Ultimate, Pear Blossom,...
Add to Basket -
Company Profile
Pear Therapeutics Inc – Company Profile
Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. The company’s lead product candidate is reSET for treating substance use disorder. Its product pipeline includes reSET-O for the treatment of opioid use disorder (OUD) in conjunction with opioid replacement therapy; Somryst against chronic insomnia; PEAR-004 targeting schizophrenia; and PEAR-006 for treating multiple sclerosis. The company’s PDT platform is developing therapies targeting Alzheimer's disease, autoimmune disorders, depression, gastrointestinal disorders, migraine, and...
Add to Basket -
Product Insights
King’s College London/ NHS – The Pears Maudsley Centre – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our King's College London/ NHS - The Pears Maudsley Centre - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Sobrato Org – 1255 Pear Avenue Mixed-Use Development – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Sobrato Org - 1255 Pear Avenue Mixed-Use Development - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...